Crossmark

Biogenic silver nanoparticles optimization using Plackett–Burman design and its synergistic effect with cefotaxime against multidrug resistant clinical isolates

Crossref DOI link: https://doi.org/10.1038/s41598-025-01524-y

Published Online: 2025-05-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Hanzala

Gul, Anum

Najam, Zainab

Malik, Taqdees
License Information

Text and Data Mining valid from 2025-05-28

Version of Record valid from 2025-05-28
More Information

Article History

Received: 3 October 2024

Accepted: 6 May 2025

First Online: 28 May 2025

Declarations

:

: The authors declare no competing interests.

: All the experiments were conducted after getting ethical approval (IRB-3393/DUHS/Exemption/2024/50) from Institutional Review Board of Dow University of Health Sciences, Karachi, Pakistan.

Document is current

Any future updates will be listed below